151 related articles for article (PubMed ID: 24860906)
1. Clinical trial rigging: again!
Prescrire Int; 2014 Apr; 23(148):110. PubMed ID: 24860906
[No Abstract] [Full Text] [Related]
2. Japanese Society of Hypertension official comment on valsartan papers.
Japanese Society of Hypertension
Hypertens Res; 2013 Nov; 36(11):923. PubMed ID: 24048487
[No Abstract] [Full Text] [Related]
3. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
[No Abstract] [Full Text] [Related]
4. [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
MMW Fortschr Med; 2004 Aug; 146(33-34):52. PubMed ID: 15526635
[No Abstract] [Full Text] [Related]
5. [VALISH].
Rakugi H; Ogihara T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
[No Abstract] [Full Text] [Related]
6. The JIKEI trial.
Boutitie F; Gueyffier F; Achard JM; Temmar M; Fournier A
Lancet; 2007 Dec; 370(9602):1825-6. PubMed ID: 18061051
[No Abstract] [Full Text] [Related]
7. Sartans for hypertension--implications of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
Cheung BM
Hong Kong Med J; 2004 Oct; 10(5):359. PubMed ID: 15479968
[No Abstract] [Full Text] [Related]
8. Valuable lessons from VALUE.
Hedner T; Kjeldsen SE; Himmelmann A
Blood Press; 2004; 13(4):196-7. PubMed ID: 15581332
[No Abstract] [Full Text] [Related]
9. [Convincing results from the JIKEI Study].
MMW Fortschr Med; 2006 Dec; 148(51-52):55. PubMed ID: 17619349
[No Abstract] [Full Text] [Related]
10. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
[No Abstract] [Full Text] [Related]
11. [Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
MMW Fortschr Med; 2006 Feb; 148(5):48-9. PubMed ID: 16518941
[No Abstract] [Full Text] [Related]
12. Angiotensin receptor blockers: baseline therapy in hypertension?
Messerli FH; Bangalore S; Ruschitzka F
Eur Heart J; 2009 Oct; 30(20):2427-30. PubMed ID: 19723696
[No Abstract] [Full Text] [Related]
13. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
[No Abstract] [Full Text] [Related]
14. [VALUE].
Okura T; Higaki J
Nihon Rinsho; 2006 Aug; 64 Suppl 6():419-24. PubMed ID: 16981573
[No Abstract] [Full Text] [Related]
15. Lowering blood pressure in acute stroke: the SCAST trial.
Hankey GJ
Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
[No Abstract] [Full Text] [Related]
16. Two amlodipine/ARB combinations for hypertension.
Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
[No Abstract] [Full Text] [Related]
17. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
[No Abstract] [Full Text] [Related]
18. Aliskiren/valsartan (Valturna) for hypertension.
Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
[No Abstract] [Full Text] [Related]
19. Exforge HCT.
Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
[No Abstract] [Full Text] [Related]
20. VALUE: analysis of results.
Fretheim A
Lancet; 2004 Sep 11-17; 364(9438):934-5; author reply 935. PubMed ID: 15364181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
